Medical Appliances: Boston Scientific Corporation (NYSE:BSX), Abbott Laboratories (NYSE:ABT), Hologic (NASDAQ:HOLX), Opko Health (NYSE:OPK)

Boston Scientific (NYSE:BSX) said it won CE Mark approval in the European Union for its Ingevity pacemaker leads, designed to be safe during MRI scans. Boston Scientific Corporation (NYSE:BSX) shares after opening at $12.75 moved to $13.20 on last trade day and at the end of the day closed at $13.01. Company price to sales ratio in past twelve months was calculated as 2.42 and price to cash ratio as 79.69. Boston Scientific Corporation (NYSE:BSX) showed a negative weekly performance of -5.04%.

Research analysts at Singular Research started coverage on shares of Abbott Laboratories (NYSE:ABT) in a report released on Monday, ARN reports. The firm set a “sell” rating and a $30.00 price target on the stock. Abbott Laboratories (NYSE:ABT) shares fell -0.66% in last trading session and ended the day on $38.97. ABT return on equity ratio is recorded as 13.30% and its return on assets is 7.20%. Abbott Laboratories (NYSE:ABT) yearly performance is 12.24%.

Hologic, Inc. (NASDAQ:HOLX) announced several organizational and leadership changes to better position the Company to achieve its corporate objectives, which include organic growth and executional excellence across its global operations. Hologic, Inc. (NASDAQ:HOLX) shares moved down -0.05% in last trading session and was closed at $21.49 while trading in range of $21.32 – $21.77 – Hologic, Inc. (NASDAQ:HOLX) year to date (YTD) performance is -3.85%.

Oppenheimer began coverage on shares of Opko Health (NYSE:OPK) in a research note issued to investors on Thursday,TheFlyOnTheWall.com reports. The firm issued an outperform rating and a $13.00 price target on the stock. Opko Health Inc. (NYSE:OPK) weekly performance is 5.11%. On last trading day company shares ended up $9.66. Opko Health Inc. (NYSE:OPK) distance from 50-day simple moving average (SMA50) is 12.37%. Analysts mean target price for the company is $12.50.